Deutsch | English | Français - CHF | EUR | USD
Analysen | Arzt | Interaktionen | Medikamente | MiGeL | Services | Spital | Zulassungsinhaber
 Sie befinden sich in - Home - Fachinformation zu Atropine 0,5%/1% SDU Faure
Fachinformation zu Atropine 0,5%/1% SDU Faure:THEA Pharma S.A.
Vollst. FachinformationDDDDrucken 
Zusammens.Galen.FormInd./Anw.mögl.Dos./Anw.Kontraind.Warn.hinw.Interakt.Schwangerschaft
Fahrtücht.Unerw.WirkungenÜberdos.Eigensch.Pharm.kinetikPräklin.Sonstige H.Swissmedic-Nr.
Reg.InhaberStand d. Info.
S01FA01 - AtropineATC-DDD Version 2012. Source: WHO
S - Sensory Organs

A formulation approved both for use in the eye/ear is classified in S03, while formulations only licensed for use in the eye or the ear are classified in S01 and S02, respectively.

S01 - Ophthalmologicals

Small amounts of antiseptics in eye preparations do not influence the classification, e.g. benzalconium.
See also S03 - Ophthalmological and otological preparations.

DDDs have been assigned for antiglaucoma preparations only.

S01F - Mydriatics and Cycloplegics
 
S01FA - Anticholinergics

Combinations with sympathomimetics are classified in this group.
Combinations with corticosteroids are classified in S01BB.

S01FA01 - Atropine
LGPL2013 ywesee.com, Commit-ID
Einstellungen | Hilfe | FAQ | Anmeldung | Kontakt | Home